The decision followed a recommendation made by the School of Biological Sciences in December 2025 to close the programme, after the School said there was no “viable long-term solution” for the sustainable delivery of clinical services within the veterinary course.
Reporting in the Financial Times said the veterinary school had been operating at losses exceeding £1 million annually.
The course had also been granted only conditional RCVS accreditation in 2024 after a visitation found it met 27 of the College’s 77 accreditation standards, with further improvements required for full approval..
The recommendation to close the school was met with significant opposition, both externally from the wider profession and internally from academics and students at Cambridge.
Responding to the news, British Veterinary Association President Dr Rob Williams MRCVS said: “We’re pleased that Cambridge University’s governing body has listened to concerns raised by BVA and so many across the whole veterinary profession and has come to the decision not to close its veterinary school.
“A resilient veterinary workforce relies on a healthy pipeline of homegrown talent and the UK’s vet schools, including Cambridge, play a crucial role in this.
“In our open letter to the school last month, we underlined how its closure would not only have represented a ‘profound gamble with public health and scientific excellence’ but also would have had a significantly negative impact on the future supply of highly skilled veterinary professionals.
“However, whilst today’s decision is a step in the right direction, it’s essential the University commits to ensuring the school is appropriately resourced to preserve its vital role at the forefront of global health and scientific leadership, now and in the future.”
The cross-sectional study, published in PLOS One, evaluated 898 dogs across 14 breeds and assessed conformational risk factors associated with BOAS.
Only 11% of Pekingese were graded free of BOAS.
Japanese Chins also showed high levels of disease, with only 17.4% graded unaffected.
King Charles Spaniels, Shih Tzus and Boston Terriers demonstrated intermediate risk profiles.
Cavalier King Charles Spaniels, Pomeranians, Boxers and Chihuahuas had substantially lower proportions of clinically affected dogs.
Across all breeds, increased facial shortening, dynamic nostril collapse and higher body condition score were significantly associated with BOAS severity.
Francesca Tomlinson, lead author and PhD researcher at the University of Cambridge, said: “Our research shows that BOAS varies widely between brachycephalic breeds.
"By understanding these differences and identifying key risk factors, we can move towards more targeted and effective strategies to improve welfare.”
The findings provide updated comparative data for clinicians advising owners on risk, weight management and early respiratory grading, and support structured respiratory grading schemes, including those led by The Royal Kennel Club.
References
The news comes only weeks after the RCVS announced conditional accreditation of the school's veterinary degree for a further year whilst further improvements could be made, having previously identified ‘wide-ranging concerns’.
The RCVS responded to the news with the following statement:
"We were very sorry to learn that Cambridge University’s Council of the School of Biological Sciences has decided to recommend to the University’s General Board that veterinary education at Cambridge should cease and, as ever, our first thoughts are with the students and staff team at the veterinary department, who will be affected directly by this news.
“As we reported on 25 November 2025, in light of the significant progress made by the vet department at Cambridge over the past 12 months towards meeting our accreditation standards, our Education Committee decided to grant conditional accreditation of the Cambridge veterinary degree programme for a further year to allow time for remaining improvements to be made.
“As stated, we appreciate the considerable efforts and hard work that the staff team at the vet department had put into rectifying many of the issues identified in the 2024 accreditation event, for taking on board the constructive advice that was given and working together to make many of the necessary improvements.'
“We had collaborated with the team within the vet department on putting together an action plan and timeline for meeting the 20 remaining recommendations, and we hoped that the department would continue on its current trajectory towards meeting our accreditation standards.
“The visitation panel noted the considerable efforts the department staff had made to make improvements in a relatively short timeframe, and the staff’s commitment to improving the remaining issues was clear. We also understood from discussions during the visitation that the department had the full and ongoing support of the School of Biological Sciences and wider University.
“In light of the School Council’s recent recommendation, however, we know that this will be a very upsetting and uncertain time for the vet department staff team and students, so we stand ready to offer as much support as we are able over the coming months.”
The BVA has also responded, it's President Dr. Rob Williams MRCVS saying: “When we met with senior leadership at Cambridge University back in June, we secured reassurances that they remained committed to the long-term future of the vet school.
"It’s therefore deeply concerning to hear that once again the future of Cambridge Vet School is in doubt.
"Working with students, alumni and staff, we’re seeking clarity on the situation and will make the case for its veterinary medicine degree course to continue."
A final decision will be made by the university's general board in January.
The new study will examine the genetic changes that occur in osteosarcoma tumours.
By understanding which genes drive the disease, researchers hope to identify biomarkers – genetic clues that could help diagnose the cancer earlier, predict prognosis for individual patients, and ultimately lead to new treatment options.
The study is looking for dogs with a confirmed or suspected diagnosis of osteosarcoma, whose treatment plan includes surgical removal of the tumour at the QVSH.
With the owner’s permission, tissue samples will be collected from the amputated limb after surgery, as well as from nearby healthy tissue for comparison.
The researchers say participation involves no additional procedures, discomfort, or hospital visits for dogs, and there is no cost to owners for the research elements of the study.
Dr Louise Van Der Weyden, study co-lead at the Wellcome Sanger Institute, said: “Our new study aims to apply genomic sequencing techniques, which have benefited humans, to canine osteosarcoma to uncover what drives these bone tumours and gain a deeper understanding of why they happen.
"We hope that by doing so, we can pave the way for the development of potential biomarkers to help early diagnosis and possibly provide future treatment options for dogs who currently have no cure.”
https://www.hospital.vet.cam.ac.uk/news/new-research-improve-diagnosis-and-treatment-canine-osteosarcoma
oncology@vet.cam.ac.uk
Dogs with RVED develop retinal degeneration from around four years of age which, if untreated, leads to blindness.
In partnership with James Oliver, Head of Ophthalmology at DWR Veterinary Specialists (pictured), researchers set out to discover why some Cocker Spaniels have such low vitamin E levels in their blood, despite it being present at normal amounts in their diet
James helped to design the study, recruit cases and collect samples.
Cathryn Mellersh, Senior Research Associate at the Canine Genetics Centre, said: “The team strongly suspected a genetic cause and has been trying to discover the responsible gene for several years with the help of owners and vets, who have contributed DNA samples.
“Thanks to updated information on the canine genome, Katherine Stanbury, one of our research associates, found a mutation in the alpha tocopherol transfer protein gene which is causative of the disease.
“This gene is responsible for getting vitamin E into the blood stream.
"We now know that RVED is a recessive disease, meaning that affected dogs must have two copies of the faulty gene to develop low vitamin E levels and retinal degeneration.”
The team’s DNA test can be used by dog breeders to find out if dogs carry the gene mutation, so they can avoid matings which result in affected puppies being born.
Cathryn said: “This DNA test is a rare example of one which not only can be used to identify dogs that are carrying the mutation and thus reduce the frequency of the mutation in future generations, but also has the incredible benefit of providing a sight-saving treatment option for dogs with the disease.
“From the research we have done we estimate that there could be several hundred Cocker Spaniels alive today that have two copies of this mutation, whose eyesight could be saved by this test.”
A DNA test for the mutation that causes RVED is now available from Canine Genetics Testing, which operates alongside researchers from the Canine Genetics Centre.
www.cagt.co.uk.
The team’s RVED research can be viewed at https://academic.oup.com/g3journal/advance-article/doi/10.1093/g3journal/jkaf016/7985679?searchresult=1
"Reasons to be fearful? Rising proportions of positive faecal worm egg counts among UK horses (2007–2023)1" which was conducted in collaboration with Animal Health Vision International, the University of Liverpool and jDATA Pty (Ltd), analysed quarterly surveillance data summaries of FWEC test results that were submitted to the Equine Quarterly Disease Surveillance report (EQDSR) by 36 UK laboratories.
Of these, 18 laboratories provided additional details through a survey on the testing methods adopted.
The researchers say there was considerable variation between laboratories in both the FWEC test methods used and the FWEC positivity thresholds applied to designate a test result as positive for either surveillance reporting or for treatment purposes.
However, the analysis revealed an increase in the proportion of positive FWECs over time, even after accounting for the time of year that testing was conducted, the FWEC positivity threshold used for reporting a sample as positive and the laboratory undertaking the testing.
Researchers say these findings raise questions about targeted treatment strategies, where anthelmintics are administered if FWECs exceed a certain threshold.
If this threshold remains low, the increasing proportion of positive FWECs that were identified would lead to increased use of wormers, potentially accelerating the development of anthelmintic resistance.
This highlights the need to better understand the factors driving rising FWEC positivity rates and if they are a cause for concern.
For example, is this trend leading to increased numbers of horses exceeding the treatment threshold and therefore being recommended for treatment?
The study authors say that the continuation of coordinated efforts to enhance parasite control strategies across the UK equine industry is essential.
The recently available guidelines from the British Equine Veterinary Association (BEVA) and CANTER provide essential resources for vets, pharmacists and RAMAs/SQPs who prescribe equine anthelmintics to optimise parasite control2,3.
The new Improve Veterinary Academy Series is comprised of five month-long semesters, each of which will focus on a different clinical topic.
Each semester will consist of videoed lectures, discussion forums, journal clubs, as well as the ability to access the university’s latest evidence-based research in these areas.
The clinical topics to be explored are:
Each semester counts towards your annual CPD requirement.
Professor James Wood, Head of the Department of Veterinary Medicine at University of Cambridge, said: “This new partnership will allow veterinary surgeons to get the latest evidence-based knowledge directly from our top specialists.
"They will also learn to apply valuable skills in their everyday practice life and engage with others on Improve International’s global, interactive online platform.
Charlotte French, Head of Curriculum & Quality at Improve International, said: “We are thrilled to be working with University of Cambridge Department of Veterinary Medicine as another innovative way to help the veterinary community take their careers to the next level.”
Professor Mike Herrtage, Trustee of the University of Cambridge Veterinary School Trust and former Dean of the Cambridge Veterinary School, said: “The new joint agreement brings together Improve International, with its outstanding record of high-quality and innovative CPD provision and the staff of the Department of Veterinary Medicine with their excellent specialist clinical knowledge and experience, as well as their recognised quality in small group teaching to stage the Improve International Academy Series.
"This will provide a new milestone in CPD course delivery.”
All practising veterinary surgeons, nurses and student nurses are invited to take part in the survey, the purpose of which is to ascertain the extent of anaesthetic monitoring, attitudes towards it and how confident people monitoring anaesthetics are.
The survey also aims to identify particular strengths and any areas of weakness, with the overall objective being to optimise vet and nurse student education and promote professional development if necessary.
The survey, which is anonymous, can be found at: https://goo.gl/Vwq1CJ. It should take 5-10 minutes to complete.
Elisabeth said: "Your opinions and experiences are extremely important to us, and we’re very grateful for your help with the survey.”